ArticleTechnology in cancer research & treatment

Addition of Camrelizumab to Transarterial Chemoembolization in Hepatocellular Carcinoma With Untreatable Progression.

Yanqiao Ren et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.